Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neurofeedback-Based Digital Therapeutics for the Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Children.

NCT06369714 is registered in ClinicalTrials.gov with Lei Lei, MD as lead sponsor.

NCT NCT06369714
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06369714 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neurofeedback-Based Digital Therapeutics for the Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Children.
Lead sponsor
Lei Lei, MD
Phase
Not applicable
Overall status
Recruiting
Start date
February 24, 2023
Completion date
December 31, 2025
Enrollment
210 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit disorder with hyperactivity, executive function disorder